DGAP-News
Epigenomics AG: Offer document published for the voluntary public takeover offer for Epigenomics AG
DGAP-News: Epigenomics AG / Key word(s): Offer Press release |
Offer document published for the voluntary public takeover offer for Epigenomics AG
Berlin, 8 June 2017 - Today Summit Hero Holding GmbH published the offer document for the voluntary takeover offer for all outstanding shares of Epigenomics AG (Frankfurt Prime Standard: ECX, OTCQX: EPGNY).
This marks the beginning of the acceptance period, in which Epigenomics shareholders can accept the cash offer of 7.52 Euros per share.
The offer price reflects a 51.9 % premium to the XETRA closing price prior to the announcement of the takeover intention as well as a 49.2 % premium to the 3-month volume weighted average share price prior to the announcement of the takeover intention.
The Executive Board and Supervisory Board of Epigenomics fully support the takeover offer. The Executive Board and Supervisory Board will carefully evaluate the offer document in the best interests of the company and provide a reasoned statement on the offer pursuant to section 27 of the German Takeover Act (Wertpapiererwerbs- und Übernahmeangebot - WpÜG). At this time, both boards assume that they will be able to recommend the offer for acceptance to shareholders.
The completion of the offer is subject to the condition, among others, that a minimum acceptance threshold of 75 percent of all Epigenomics shares is reached. All relevant regulatory approvals have already been granted.
The acceptance period lasts through 7 July 2017. The additional acceptance period is anticipated to begin on 13 July 2017 and ends on 26 July 2017 at midnight. With the successful completion of the offer, the purchase price will be paid shortly after the expiry of the acceptance period or - with acceptance of the offer during the additional acceptance period - shortly after its expiry. The additional acceptance period will only begin if all offer conditions, including the minimum acceptance threshold, were fulfilled within the first acceptance period.